Aurobindo Loses Fee Bid After Beating Mucinex Patent Suit
A Delaware federal judge has rejected generics maker Aurobindo Pharma Ltd.'s request for attorneys' fees after it won a patent case brought by Reckitt Benckiser LLC over the cold and flu...To view the full article, register now.
Already a subscriber? Click here to view full article